NHS National Generics Pharmaceuticals Transition 2023_1

Tender description

Framework agreement for NHS National Generics Pharmacuticals Transition 2023_1. Offer reference number CM/PHG/22/5666.<br/><br/>Potential periods of call-offs under the framework agreement:<br/> CM/PHG/22/5666/00 – Transition Products:<br/>CESW- /08/2023 – 31/01/2024 (6 months) <br/>NWLN 01/08/2023 – 31/01/2025 (18 months)<br/>LSNE 01/08/2023 – 31/05/2024 (10 months) <br/> <br/>CM/PHG/22/5666/01 – Orals (plus non-parenteral) Products: <br/>All regions: 01/08/2023 to 31/05/2024 (10 Months) Lot 1: Lot 1 - CM/PHG/22/5666/00 - Supplier offer confirmation (Check box) Invitation to offer for NHS National Generics Pharmaceuticals Transition 2023_1<br/><br/>Period of framework agreement: The total maximum duration of the framework agreement to be no more than 18 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months. <br/><br/>CM/PHG/22/5666/00 – Transition Products:<br/>CESW 01/08/2023 – 31/01/2024 (6 months) <br/>NWLN 01/08/2023 – 31/01/2025 (18 months)<br/>LSNE 01/08/2023 – 31/05/2024 (10 months) <br/> <br/>CM/PHG/22/5666/01 – Orals (plus non-parenteral) Products: <br/>All regions: 01/08/2023 to 31/05/2024 (10 Months) Lot 2: Lot 2 - CM/PHG/22/5666/01 - Supplier offer confirmation (Check box) Invitation to offer for NHS National Generics Pharmaceuticals Transition 2023_1<br/><br/>Period of framework agreement: The total maximum duration of the framework agreement to be no more than 18 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months.<br/><br/>CM/PHG/22/5666/00 – Transition Products:<br/>CESW 01/08/2023 – 31/01/2024 (6 months)<br/>NWLN 01/08/2023 – 31/01/2025 (18 months)<br/>LSNE 01/08/2023 – 31/05/2024 (10 months)<br/><br/>CM/PHG/22/5666/01 – Orals (plus non-parenteral) Products:<br/>All regions: 01/08/2023 to 31/05/2024 (10 Months)